Patent ID: 8557255
Filing Date: 2013-10-15
Classification: A61K,A61P,A61Q,Y02A

Abstract:
1. A method of treating a disease or condition caused by or associated with hyperactive cholinergic innervation of muscles or exocrine glands in a patient, the method comprising administering a composition comprising a therapeutically effective amount of a neurotoxic component of a Clostridium botulinum toxin complex serotype A or subtypes, the composition being devoid of any other protein component of the Clostridium botulinum toxin complex, to remove partially or completely the treated disease or condition symptoms, wherein (a) the patient is a human, (b) the composition is administered by injection, and (c) the composition is locally administered in a non-lethal dose to a muscle or exocrine gland exhibiting hyperactive cholinergic innervation at an interval of less than eight weeks, the interval comprising a first treatment and a second treatment, wherein the amount administered in the second treatment can be lower, higher or identical to the amount administered in the first treatment, and (d) the therapeutically effective amount of a non-lethal dose of the neurotoxic component of